Press Releases-SINOVAC: Supply Vaccines to Eliminate Human Diseases-page1

2015/12/10

Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate

2015/11/12

Sinovac Reports Unaudited Third Quarter Financial Results

2015/11/04

Sinovac to Participate in Morgan Stanley Asia Pacific Summit

2015/11/02

Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results

2015/10/26

Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate

2015/09/14

Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing

2015/09/10

Sinovac to Participate in Morgan Stanley Global Healthcare Conference

2015/08/13

Sinovac Reports Unaudited Second Quarter Financial Results

BEIJING, Aug.12, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2015.

2015/08/11

Sinovac Announces Results of 2015 Annual General Meeting of Shareholders

2015/08/04

Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results

2015/07/08

Sinovac Schedules 2015 Annual Meeting of Shareholders

2015/05/15

Sinovac Reports Unaudited First Quarter 2015 Financial Results

2015/05/14

Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities

2015/05/12

Sinovac to Participate in UBS Global Healthcare Conference

2015/05/07

Sinovac to Host Conference Call to Report First Quarter 2015 Unaudited Financial Results

2015/04/29

Sinovac Files 2014 Annual Report on Form 20-F

2015/04/20

Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results

2015/04/10

Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2014 Unaudited Financial Results

2015/03/18

Sinovac to Participate in China Medical and Healthcare Investment Conference

2015/03/17